IBDEI1BS ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23738,0)
 ;;=51726^^151^1512^5^^^^1
 ;;^UTILITY(U,$J,358.3,23738,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23738,1,2,0)
 ;;=2^51726
 ;;^UTILITY(U,$J,358.3,23738,1,3,0)
 ;;=3^Cystometrogram,Complex
 ;;^UTILITY(U,$J,358.3,23739,0)
 ;;=51797^^151^1512^8^^^^1
 ;;^UTILITY(U,$J,358.3,23739,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23739,1,2,0)
 ;;=2^51797
 ;;^UTILITY(U,$J,358.3,23739,1,3,0)
 ;;=3^Intra-Abdominal Voiding Pressure (Rectal)
 ;;^UTILITY(U,$J,358.3,23740,0)
 ;;=51785^^151^1512^6^^^^1
 ;;^UTILITY(U,$J,358.3,23740,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23740,1,2,0)
 ;;=2^51785
 ;;^UTILITY(U,$J,358.3,23740,1,3,0)
 ;;=3^EMG Needle
 ;;^UTILITY(U,$J,358.3,23741,0)
 ;;=51741^^151^1512^10^^^^1
 ;;^UTILITY(U,$J,358.3,23741,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23741,1,2,0)
 ;;=2^51741
 ;;^UTILITY(U,$J,358.3,23741,1,3,0)
 ;;=3^Uroflow;Complex
 ;;^UTILITY(U,$J,358.3,23742,0)
 ;;=51792^^151^1512^12^^^^1
 ;;^UTILITY(U,$J,358.3,23742,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23742,1,2,0)
 ;;=2^51792
 ;;^UTILITY(U,$J,358.3,23742,1,3,0)
 ;;=3^Vib. Stimulation Study
 ;;^UTILITY(U,$J,358.3,23743,0)
 ;;=51798^^151^1512^9^^^^1
 ;;^UTILITY(U,$J,358.3,23743,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23743,1,2,0)
 ;;=2^51798
 ;;^UTILITY(U,$J,358.3,23743,1,3,0)
 ;;=3^US For Residual Urine
 ;;^UTILITY(U,$J,358.3,23744,0)
 ;;=51727^^151^1512^3^^^^1
 ;;^UTILITY(U,$J,358.3,23744,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23744,1,2,0)
 ;;=2^51727
 ;;^UTILITY(U,$J,358.3,23744,1,3,0)
 ;;=3^Cystometrogram,Comp w/UP Study
 ;;^UTILITY(U,$J,358.3,23745,0)
 ;;=51728^^151^1512^2^^^^1
 ;;^UTILITY(U,$J,358.3,23745,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23745,1,2,0)
 ;;=2^51728
 ;;^UTILITY(U,$J,358.3,23745,1,3,0)
 ;;=3^Cystometrogram,Comp w/ VP
 ;;^UTILITY(U,$J,358.3,23746,0)
 ;;=51729^^151^1512^4^^^^1
 ;;^UTILITY(U,$J,358.3,23746,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23746,1,2,0)
 ;;=2^51729
 ;;^UTILITY(U,$J,358.3,23746,1,3,0)
 ;;=3^Cystometrogram,Comp w/VP&UP
 ;;^UTILITY(U,$J,358.3,23747,0)
 ;;=51736^^151^1512^11^^^^1
 ;;^UTILITY(U,$J,358.3,23747,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23747,1,2,0)
 ;;=2^51736
 ;;^UTILITY(U,$J,358.3,23747,1,3,0)
 ;;=3^Uroflow;Simple
 ;;^UTILITY(U,$J,358.3,23748,0)
 ;;=51784^^151^1512^7^^^^1
 ;;^UTILITY(U,$J,358.3,23748,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23748,1,2,0)
 ;;=2^51784
 ;;^UTILITY(U,$J,358.3,23748,1,3,0)
 ;;=3^EMG Non-Needle
 ;;^UTILITY(U,$J,358.3,23749,0)
 ;;=J9202^^151^1513^26^^^^3
 ;;^UTILITY(U,$J,358.3,23749,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23749,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,23749,1,3,0)
 ;;=3^Zoladex, 10.8 mg total
 ;;^UTILITY(U,$J,358.3,23750,0)
 ;;=96401^^151^1513^7^^^^1
 ;;^UTILITY(U,$J,358.3,23750,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23750,1,2,0)
 ;;=2^96401
 ;;^UTILITY(U,$J,358.3,23750,1,3,0)
 ;;=3^Chemotherapy,IM/SQ
 ;;^UTILITY(U,$J,358.3,23751,0)
 ;;=96402^^151^1513^15^^^^1
 ;;^UTILITY(U,$J,358.3,23751,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23751,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,23751,1,3,0)
 ;;=3^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,23752,0)
 ;;=96372^^151^1513^1^^^^1
 ;;^UTILITY(U,$J,358.3,23752,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23752,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,23752,1,3,0)
 ;;=3^Administration of Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,23753,0)
 ;;=96374^^151^1513^14^^^^1
 ;;^UTILITY(U,$J,358.3,23753,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23753,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,23753,1,3,0)
 ;;=3^IV Push,Single Non-Chemo Drug
